Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients

Kidney International

Volumn 74, Issue 12, 2008, Pages 1603-1609

  Maruyama, Shoichi ^a   Taguchi, Akihiko ^b   Iwashima, Shigejiro ^a   Ozaki, Takenori ^a   Yasuda, Kaoru ^a   Kikuchi Taura, Akie ^c   Soma, Toshihiro ^c   Ishii, Hideki ^a   Murohara, Toyoaki ^a   Takahashi, Hiroshi ^d   Kasuga, Hirotake ^d   Kumada, Yoshitaka ^d   Toriyama, Takanobu ^d   Ito, Yasuhiko ^a   Kawahara, Hirohisa ^d   Yuzawa, Yukio ^a   Matsuo, Seiichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^d Nagoya Kyoritsu Hospital   (Japan)

Author keywords

Cardiovascular disease; Dialysis; Endothelial progenitor cells; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CD34 SELECTION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, CD34; BLOOD CELL COUNT; BLOOD CELLS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; FLOW CYTOMETRY; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL DIALYSIS; ROC CURVE;

EID: 57049109810     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.495     Document Type: Article

References (23)

1. Pastan S, Bailey J. Dialysis therapy. N Engl J Med 1998; 338: 1428-1437.
2. Moeslinger T, Spieckermann PG. Urea-induced inducible nitric oxide synthase inhibition and macrophage proliferation. Kidney Int Suppl 2001; 78: S2-S8.
3. Cheung AK, Sarnak MJ, Yan G et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362.
4. Yasuda K, Kasuga H, Aoyama T et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol 2006; 17: 2322-2332.
5. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
6. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660.
7. Majka M, Janowska-Wieczorek A, Ratajczak J et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001; 97: 3075-3085.
8. Schmidt-Lucke C, Rossig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987.
9. Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
10. Okada S, Makino H, Nagumo A et al. Circulating CD34-positive cell number is associated with brain natriuretic peptide level in type 2 diabetic patients. Diabetes Care 2008; 31: 157-158.
11. Taguchi A, Matsuyama T, Moriwaki H et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004; 109: 2972-2975.
12. Taguchi A, Matsuyama T, Nakagomi T et al. Circulating CD34-positive cells provide a marker of vascular risk associated with cognitive impairment. J Cereb Blood Flow Metab 2008; 28: 445-449.
13. de Groot K, Bahlmann FH, Sowa J et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004; 66: 641-646.
14. Choi JH, Kim KL, Huh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246-1252.
15. Eizawa T, Murakami Y, Matsui K et al. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 2003; 19: 627-633.
16. Steiner S, Schaller G, Puttinger H et al. History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients. Am J Kidney Dis 2005; 46: 520-528.
17. Taguchi A, Soma T, Tanaka H et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004; 114: 330-338.
18. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435.
19. Fadini GP, de Kreutzenberg SV, Coracina A et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006; 27: 2247-2255.
20. Kikuchi-Taura A, Soma T, Matsuyama T et al. A new protocol for quantifying CD34(+) cells in peripheral blood of patients with cardiovascular disease. Tex Heart Inst J 2006; 33: 427-429.
21. Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5: 213-226.
22. Shoji T, Tsubakihara Y, Fujii M et al. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004; 66: 1212-1220.
23. Koc M, Richards HB, Bihorac A et al. Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int 2005; 67: 1078-1083.